Mark R. Hake

Mark R. Hake

Mark R. Hake, CFA is a financial analyst and entrepreneur. He has been a Chartered Financial Analyst (CFA) for 31 years and has owned his own investment management and investment research firms that focused on value stocks, both in the U.S. and overseas.

Mark writes over 600 articles per year on stocks, cryptos, SPACs, convertibles, ETFs, and other financial securities. He has been ranked with 5 stars by TipRanks.com (under “Mark R. Hake”) with an average return of over 22% annually and #36 out of 8,116 writers. Presently he authors articles on Medium.com and other sites.

Mark also invests in public and private equities and has acted as a hedge fund manager and portfolio manager for various money management firms. He has also acted as CFO and Chief Strategy Officer for several fin-tech and software companies.

You can follow Mark on LinkedIn and on TipRanks.

Recent Articles

Analysts Seem To Love Virgin Galactic, But The Company Still Has To Perform

Analysts love Virgin Galactic, but it has yet to perform. SPCE stock has analysts with price targets from $34 to $50, but its operations have yet to take off.

7 High-Yield Dividend Stocks With Enough Earnings to Cover the Dividends

These 7 high-yield dividend stocks have yields above 5% and their payout ratios broadly look strong enough to support those dividends.

Snowflake Stock Could Tread Water as Cloud SaaS Grows Into Its Valuation

SNOW stock is still at sky-high levels, but as sales and earnings rise its valuation will come down.

Airbnb Stock Is a Clear Winner When Compared to Square

When do you do a take rate comparison and examine the free cash flow of Airbnb and Square, ABNB stock comes out as the clear winner.

Nikola Stock Might Be an Interesting Contrarian Play Now

Nikola stock might be an interesting contrarian play now. Probability analysis says NKLA may be a buy if the company meets its milestones in 2021.

Second Sight May Take Another Look at Giving Up Control

Second Sight Will Probably Take a Second Look at Giving Up Control. EYES stock will probably rise if the company backs off of the sale of 60% to Pixium Vision.

Why the Social Finance Merger Deal With IPOE Stock Looks Undervalued

The Social Finance merger deal with IPOE stock looks undervalued. IPOE stock is potentially worth 30% more at $23.91 once the SPAC merger with Sofi closes.

Luckin Coffee Stock Will Likely Rise If It Exits Bankruptcy

Luckin stock might have a chance of exiting bankruptcy if the company raises the $250 million in capital that it plans to.

Apex Technology Should Surge When It Closes Its AvePoint Merger

Apex Technology will rise when it closes its AvePoint merger. APXT stock, which will change to AVPT stock when the SPAC merger closes, is worth 28% to 65% more.

Guardion Health Sciences Is Burning Through Its Cash Raise Too Fast

Guardion Health Sciences is burning through its cash too fast. Be cautious with GHSI stock as the price won't rise without an acquisition.